Results 241 to 250 of about 2,227,737 (406)

Vericiguat in the management of heart failure with reduced ejection fraction

European Heart Journal - Cardiovascular Pharmacotherapy, 2021
Haya Aziz, Pishoy Gouda, Abhinav Sharma
openaire   +2 more sources

Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.

Journal of the American College of Cardiology, 2018
S. Greene, J. Butler, N. Albert, A. DeVore, Puza P. Sharma, Carol I. Duffy, C. L. Hill, K. Mccague, Xiaojuan Mi, J. Patterson, J. Spertus, L. Thomas, Fredonia B. Williams, Adrian F. Hernandez, G. Fonarow   +14 more
semanticscholar   +1 more source

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

The Lancet, 2020
M. Vaduganathan, B. Claggett, P. Jhund, J. Cunningham, J. Ferreira, F. Zannad, M. Packer, G. Fonarow, J. McMurray, S. Solomon   +9 more
semanticscholar   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato, Rebecca Ross, Ranjitha Karanth, Vishal Kakkar, Enrico De Lorenzis, Lesley‐Anne Bissell, Kristina Clark, Philip Yee, Christopher P. Denton, Francesco Del Galdo   +9 more
wiley   +1 more source

Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction [PDF]

, 2015
Katsuya Kajimoto, Naoki Sato, Teruo Takano   +2 more
openalex   +1 more source

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this phase 1 trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone (previously AZD9977) in participants with severe renal impairment vs. those with normal renal function. Methods Participants with severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2) not on dialysis were ...
Chandrali S. Bhattacharya, Hans Ericsson, Susanne Johansson, Joanna Parkinson, Simina M. Boca, Ye Yang, Maria Heijer, Greggory Housler, Maria Leonsson‐Zachrisson, Judith Hartleib‐Geschwindner, Patricia Ely Pizzato   +10 more
wiley   +1 more source

Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol

, 2013
Yoshihiro Mori, Yasuhiro Nishikawa, Fumiaki Kobayashi, Katsutoshi Hiramatsu   +3 more
openalex   +2 more sources

Serum Concentrations of Heme Oxigenase-1 are Reduced in Patients with Acute Heart Failure and Preserved Ejection Fraction [PDF]

, 2015
Paulino Álvarez, Andrea M. Cordero‐Reyes, Keith A. Youker, Javier Amione‐Guerra, César Uribe, Arvind Bhimaraj, Barry Trachtenberg, Ashrith Guha, Vijay Nambi, Guillermo Torre‐Amione, Jerry D. Estep   +10 more
openalex   +1 more source

Anticoagulation intensity and outcomes among southeast‐Asians with moderate‐to‐severe mitral valve stenosis

British Journal of Clinical Pharmacology, EarlyView.
Objective To determine the optimal anticoagulation intensity of warfarin in a South‐East Asian population with moderate‐to‐severe rheumatic mitral stenosis. Methods A multicentre, retrospective study examined patients with rheumatic mitral stenosis who had not undergone valve replacement or repair and required long‐term warfarin therapy at two ...
Punyawee Puchsaka, Wipharak Rattanavipanon, Sararat Phetroong, Rudeekorn Ue‐sethasakdhi, Suparat Wattanasombat, Wattana Wongtheptien, Surakit Nathisuwan   +6 more
wiley   +1 more source

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis

Heliyon
Background: Few studies have compared the performances of those reported miRNAs as biomarkers for heart failure with reduced EF (HFrEF) in a population at high risk.
Zheng Kuai, Yuanji Ma, Wei Gao, Xiaoxue Zhang, Xiaoyan Wang, Yangli Ye, Xiaoyi Zhang, Jie Yuan   +7 more
doaj